Drug Regulatory Affairs

Regulatory Affairs is involved in the development of new medicinal products from early on, by integrating regulatory principles and by preparing and submitting the relevant regulatory dossiers to health authorities. Regulatory Affairs is involved in every step of the development of a novel medicine and in the post-marketing activities with medicinal products.

  • Regulatory science
  • Dosage form
  • Thin-film drug delivery

    Related Conference of Drug Regulatory Affairs

    October 23-24, 2025

    21st Annual Meet on Pharmaceutical Sciences

    Paris, France
    November 11-12, 2025

    6th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    December 30-31, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy

    Drug Regulatory Affairs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in